A ten-amino-acid opioid peptide from the prodynorphin family — kissing cousin of the dynorphins and, like them, a κ-receptor ligand. It rounds out the brain's κ-opioid toolkit alongside dynorphin A, dynorphin B and its own sibling β-neoendorphin.
The reviewed human PDYN record maps α-neoendorphin to precursor residues 175–184 and β-neoendorphin to 175–183. Thus the two peptides differ by one terminal lysine, rather than being two ten-residue sequences. Both begin with the five-residue Leu-enkephalin motif. These coordinates identify the molecules directly and distinguish their sequences from the longer dynorphin peptides produced elsewhere in the same precursor.
κ-preferring opioid agonism with the standard Gi/o output — reduced transmitter release and neuronal inhibition (opioid receptors; signaling pathway). Its shorter length relative to dynorphin A relaxes κ selectivity somewhat, giving it mixed κ/δ character.
The family relationship does not make the individual peptides interchangeable. A study of the combined dynorphin–κ-receptor system can establish a circuit-level effect without identifying which processed peptide supplied it. Sequence-specific measurements and receptor assays are therefore needed when attributing a particular effect to one neoendorphin. This matters when comparing tissue extracts, precursor-gene expression and experiments using a single synthetic peptide.